Company Filing History:
Years Active: 2018
Title: Jeanette Boudreau: Innovator in KIR3DL1 Allele Classification
Introduction
Jeanette Boudreau is a notable inventor based in New York, NY (US). She has made significant contributions to the field of genetics, particularly in the classification of KIR3DL1 alleles. Her work is essential for advancing clinical practices and research methodologies.
Latest Patents
Jeanette holds a patent for the "KIR3DL1 allele classification kit and method." This patent discloses single nucleotide polymorphisms (SNPs) that are characteristic of functional subgroups of KIR3DL1. The methods outlined in her patent utilize a series of oligonucleotide primers and PCR reaction conditions specifically designed to identify group-specific SNPs from genomic DNA. This innovation is particularly useful in clinical settings and research laboratories, enabling the prospective assessment of prognoses for various diseases and the selection of the most appropriate donors for hematopoietic cell transplantation (HCT).
Career Highlights
Jeanette Boudreau is affiliated with the Memorial Sloan Kettering Cancer Center, where she continues to contribute to groundbreaking research in cancer treatment and genetics. Her work has implications for improving patient outcomes and advancing the understanding of genetic factors in disease.
Collaborations
Jeanette collaborates with several professionals in her field, including her coworker, Katharine Hsu. Their combined expertise enhances the research efforts at their institution.
Conclusion
Jeanette Boudreau's innovative work in KIR3DL1 allele classification represents a significant advancement in genetic research and clinical applications. Her contributions are vital for improving patient care and understanding genetic diseases.